Back to Search
MIKHAIL SHTIVELBAND, MD
MD
Hematology & Oncology Physician
NPI: 1740254473IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
32733(AZ)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1991
Research & Publications (5)
Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate.
PMID 15738002·J Biol Chem·2005
4-observational
Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
PMID 15009722·J Invest Dermatol·2004
7-preclinical
A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
PMID 14695161·Clin Cancer Res·2003
7-preclinical
Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression.
PMID 14521608·J Thromb Haemost·2003
8-other
Purification and characterization of a cyclooxygenase-2 and angiogenesis suppressing factor produced by human fibroblasts.
PMID 12060668·FASEB J·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via 685 S Dobson Rd · 2 locations total
- Address
- 685 S DOBSON RD
CHANDLER, AZ 85224 - Phone
- (480) 821-2838
Quick Facts
- NPI
- 1740254473
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 35
- Publications
- 5
Are you this provider?
Claim Your Profile